source
- Novartis faces another setback while Novo drops Nordisk partnershipThe latest edition of Endpoints Weekly notes that Novartis experienced another failure, though the newsletter does not provide details about the product or trial. It also reports that Novo Nordisk…
- FDA clears Aptitude’s latest Metrix molecular dx to test for COVIDThe FDA granted Aptitude its first 510(k) clearance for the next-generation Metrix COVID diagnostic that features three-times greater sensitivity with 30% faster results that its original emergency…